Refine
Has Fulltext
- yes (118)
Is part of the Bibliography
- yes (118)
Year of publication
Document Type
- Journal article (118) (remove)
Language
- English (118) (remove)
Keywords
- Neisseria meningitidis (13)
- Echinococcus (6)
- Tanzania (6)
- meningococcal disease (6)
- Aspergillus (4)
- Germany (4)
- antimicrobial resistance (4)
- neisseria meningitidis (4)
- stem cells (4)
- COVID-19 (3)
- MRSA (3)
- Meningitis (3)
- SARS-CoV-2 (3)
- infection (3)
- inflammation (3)
- meningitis (3)
- multilocularis (3)
- ARONJ (2)
- Apoptosis (2)
- BDG (2)
- C5aR1 (2)
- Candida auris (2)
- Echinococcosis (2)
- Fusarium (2)
- Group B Streptococcus (2)
- HBMEC (2)
- Haemophilus influenzae (2)
- Neisseria gonorrhoeae (2)
- Rhizopus (2)
- Stem cell (2)
- Ureaplasma parvum (2)
- Ureaplasma urealyticum (2)
- alveolar echinococcosis (2)
- antigen (2)
- antimicrobial stewardship (2)
- bacteria (2)
- bacterial meningitis (2)
- bacterial pathogens (2)
- beta-D-glucan (2)
- blood–brain barrier (2)
- brain endothelial cells (2)
- candidemia (2)
- colonization (2)
- comparative genomics (2)
- diagnosis (2)
- echinococcus multilocularis (2)
- galactomannan (2)
- gene conversion (2)
- gene expression (2)
- genome sequencing (2)
- granulocytes (2)
- haemophilus influenzae (2)
- homologous recombination (2)
- infection control (2)
- men who have sex with men (2)
- microbiology (2)
- neuroinflammation (2)
- neutrophils (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- outer membrane protein (2)
- pathogens (2)
- platyhelminthes (2)
- sepsis (2)
- sphingolipids (2)
- surgical site infection (2)
- transcriptome (2)
- 5-methyl cytosine (1)
- Acetylated tubulin (1)
- Alkaline phosphatase (1)
- Alternaria (1)
- Argonaute (1)
- Ascaris lumbricoides (1)
- Aspergillus fumigatus (1)
- AurisID (1)
- B neisseria meningitidis (1)
- BacT/ALERT (1)
- Bacterial meningitis (1)
- Benzimidazoles (1)
- Biohazard (1)
- Brain endothelial cells (1)
- Brugia Malayi (1)
- C-reactive protein (1)
- C3a (1)
- C3aR (1)
- C5a (1)
- C5aR2 (1)
- CCL3 (1)
- CCL4 (1)
- CCL5 (1)
- COVID-19 testing (1)
- COVID‐19 (1)
- CPG binding domain (1)
- Calibration (1)
- Cancer treatment (1)
- Candida albicans (1)
- Candida lusitaniae (1)
- Caspase (1)
- Ceramide (1)
- Cestoda (1)
- Cestoda Taeniidae (1)
- Cestode (1)
- Chagas disease (1)
- Circinella (1)
- Clinical prediction rule (1)
- Colombia (1)
- Colonization (1)
- Community-acquired methicillin-resistant Staphylococcus aureus (1)
- DNA methylation (1)
- DNA recombination (1)
- Densovirus (1)
- Disaster response (1)
- ESBL (1)
- Efflux transport (1)
- Elderly (1)
- Emergence (1)
- Enterobacteriaceae (1)
- Epigenetic (1)
- Escherichia coli K1 (1)
- Escherichia coli infections (1)
- Europe (1)
- Expansion microscopy (1)
- False positive reactions (1)
- FinO family (1)
- Fks1 (1)
- FoxQ2 (1)
- Fungiplex Candida Auris (1)
- GM (1)
- Gene silencing (1)
- Geriatric care (1)
- Geriatrics (1)
- Germinative cell (1)
- Golgi (1)
- HFQ (1)
- HIV (1)
- Hospital emergency plan (1)
- Host-parasite interaction (1)
- Host-pathogen interactions (1)
- I-lactate (1)
- IA (1)
- ICM (1)
- IDSA (1)
- IMD (1)
- IctP (1)
- Inducible Clindamycin Resistance (1)
- Infection control (1)
- Insulin (1)
- Jurkat cells (1)
- Kinase inhibitor (1)
- LTR retrotransposons (1)
- Larvae (1)
- Lichtheimia (1)
- Listeria monocytogenes (1)
- MITE (1)
- MLST (1)
- MRONJ (1)
- MSIS (1)
- Mass critical care (1)
- Medicine (1)
- Medizin (1)
- Meningococcal infection (1)
- Meningococcal polysaccharide caccine (1)
- Meningococcal serogroup C (1)
- Meningococci (1)
- Mesocestoides corti (1)
- Metacestode (1)
- Methicillin resistant Staphylococcus aureus (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methicillin-resistant staphylococcus aureus (1)
- Mikrobiologie (1)
- Mobile genetic element (1)
- Mucin (1)
- Mucor (1)
- Mucorales (1)
- Multiplex PCR (1)
- Mwanza (1)
- Mycobacterium marinum (1)
- N-oleoyl serinol (1)
- NAS (1)
- Nanos (1)
- Nasal Carriage (1)
- Neisseria (1)
- Neoblast (1)
- Nervous system (1)
- Neuroinfectiology (1)
- Neuroinflammation (1)
- Neuropeptide (1)
- Nursing homes (1)
- ONJ (1)
- One Health (1)
- P-glycoprotein (1)
- P-gp (1)
- P. aeruginosa (1)
- PMNs (1)
- Parvovirus (1)
- Pathogens (1)
- Pentastomiasis (1)
- Pneumococci (1)
- Predictive value of tests (1)
- Prevalence (1)
- Protoscolex (1)
- Purpureocillium (1)
- RNA (1)
- RNA chaperone Hfq (1)
- Receptor kinase (1)
- Rhizomucor (1)
- S. aureus (1)
- SARS‐CoV‐2 (1)
- SFRP (1)
- ST 772 (1)
- ST1797 (1)
- ST88 (1)
- Scedosporium (1)
- Schistosoma mansoni (1)
- Sequence motif analysis (1)
- Serotonin (1)
- Sierra Nevada (1)
- Six3/6 Wnt (1)
- Skin (1)
- Staphylococcus aureus (1)
- Stem cells (1)
- Streptococcus agalactiae (1)
- Streptococcus suis (1)
- Surgery (1)
- T Cells (1)
- T cells (1)
- TGF-BETA (1)
- TNF-alpha (1)
- Tapeworm (1)
- Tropheryma whipplei (1)
- Tuberculosis (1)
- Ureaplasma (1)
- Ureaplasma species (1)
- Vaccination (1)
- Valentine Leukocidin Genes (1)
- Vesicles (1)
- WBC (1)
- Whipple's disease (1)
- Xenopus oocytes (1)
- acute watery diarrhea (1)
- admission screening (1)
- agar (1)
- agar diffusion test (1)
- alloSCT patients (1)
- alternative pig farming (1)
- alveoar echinococcosis (1)
- ampicillin (1)
- anaphylatoxins (1)
- anidulafungin (1)
- antero-posterior axis (1)
- antibiotic bone concentration (1)
- antibiotic prescription behavior (1)
- antibiotic use (1)
- antibodies (1)
- anticoagulants (1)
- antifungal susceptibility (1)
- antifungals (1)
- antigen testing (1)
- antigen-B (1)
- antigens (1)
- antimicrobial responses (1)
- antimicrobials (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- anxiety (1)
- assay (1)
- attitude of health personnel (1)
- atypical chemokine receptor 3 (1)
- aureus infections (1)
- autochthonous infection (1)
- azole resistance (1)
- bactericidal activity (1)
- benzimidazole (1)
- beta-lactam (1)
- beta-tubulin (1)
- beta‐d‐glucan (1)
- biological techniques (1)
- biomarker (1)
- biosynthesis (1)
- blood (1)
- blood fluke (1)
- blood stream infections (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- bloodstream infection (1)
- brain barrier (1)
- brain endothelial cell (1)
- breakthrough (1)
- bronchoalveolar lavage fluid (1)
- campylobacteriosis (1)
- cardiovascular MRI (1)
- caspase-3 (1)
- caspofungin (1)
- cell staining (1)
- cell wall (1)
- cells (1)
- central-nervous-system (1)
- cephalosporin-resistant gram-negative bacteria (1)
- ceramide (1)
- ceramide analogs (1)
- cestodes (1)
- chaperone (1)
- chemical properties (1)
- chemotherapy (1)
- children (1)
- chorioamnionitis (1)
- choroid-plexus (1)
- circulating (1)
- coagulase-negative staphylococci (1)
- commercial kits (1)
- community settings (1)
- complement system (1)
- complex (1)
- cord blood (1)
- corticosteroids (1)
- cryptic (1)
- cutibacteria (1)
- cytokines (1)
- dRNA-seq (1)
- dendritic cells (1)
- depression (1)
- detection limits (1)
- differential age distribution (1)
- digital phenotyping (1)
- disease-associated (1)
- dual function (1)
- echinocandin (1)
- echinocandins (1)
- echinococcosis (1)
- ecological momentary assessment (1)
- ecology (1)
- efflux pumps (1)
- elucidation (1)
- endophthalmitis (1)
- endothelial cells (1)
- epgenetics (1)
- epidemiology (1)
- epidermal growth factor (1)
- epithelial cells (1)
- excretory-secretory (1)
- expert recommendation (1)
- extracellular (1)
- eye infection (1)
- factor H (1)
- feasibility study (1)
- field gel-electrophoreresis (1)
- flatworm (1)
- flow cytometry (1)
- fluorescence microscopy (1)
- fungal antigens (1)
- fungal infection (1)
- fungal molecular diagnostics (1)
- fungi (1)
- fungicidal activity (1)
- galectin-2 (1)
- gangliosides and lipid rafts (1)
- gen (1)
- gene (1)
- general practice (1)
- general practitioner (1)
- generalized anxiety disorder (1)
- genetic loci (1)
- genetic variation (1)
- genetics (1)
- genome (1)
- genomic databases (1)
- genomic libraries (1)
- germinative cells (1)
- glucan synthase (1)
- glutamate dehydrogenase (1)
- glutathione (1)
- granulosus (1)
- group-B (1)
- heart (1)
- hematopoietic stem cell transplantation (1)
- hemihepatectomy (1)
- hospital-acquired methicillin-resistant Staphylococcus aureus (1)
- host defense (1)
- host response (1)
- host-pathogen interaction (1)
- host-pathogen interactions (1)
- host–pathogen interaction (1)
- human behaviour (1)
- human brain microvascular endothelial cells (1)
- hydatid disease (1)
- hydrogels (1)
- hyphae (1)
- identification (1)
- imaging (1)
- immune evasion (1)
- immune impairment (1)
- immune response (1)
- immunogenetics (1)
- immunology (1)
- immunomodulation (1)
- immunoprecipitation (1)
- immunotherapy (1)
- in vitro (1)
- in vivo (1)
- indigenous (1)
- induced pluripotent stem cells (1)
- infection prevention (1)
- infectious diseases management (1)
- innate immune evasions (1)
- innate immune response (1)
- interstage aspiration (1)
- intervention strategies (1)
- intravenous ceftriaxone (1)
- intravitreal vancomycin and amikacin (1)
- invasive aspergillosis (1)
- invasive disease (1)
- invasive meningococcal disease (1)
- invasive pulmonary aspergillosis (1)
- jaw bone (1)
- joint aspiration (1)
- joint infection (1)
- keratitis (1)
- killing (1)
- knowledge (1)
- laboratory techniques and procedures (1)
- large animal models (1)
- larvae (1)
- leptomeningeal cells (1)
- leucocyte count (1)
- liver (1)
- liver resection (1)
- livestock-associated staphylococci (1)
- long noncoding RNA (1)
- longitudinal studies (1)
- mammalian genomics (1)
- mannan (1)
- marker (1)
- matrix metallopeptidase-1 (1)
- maximum liklihood (1)
- mebendazole (1)
- meningeal blood-csf barrier (1)
- meningococcal lineages (1)
- meningococcal polysaccharides (1)
- meningococcus (1)
- metabolism (1)
- metacestode vesicles (1)
- metamorphosis (1)
- methyltransferase homolog (1)
- micafungin (1)
- mice (1)
- microRNA (1)
- microbial surface component recognising adhesive matrix molecules (1)
- microbiological culture (1)
- microbiology techniques (1)
- microscopy (1)
- microvascular endothelial cells (1)
- microvascular endothelial-cells (1)
- mitochondria (1)
- mitochondrial dynamics (1)
- mitochondrial morphology (1)
- mobile crowdsensing (1)
- mobile health (1)
- molecular characterization (1)
- molecular epidemiology (1)
- monoclonal antibody (1)
- monocytes (1)
- mouse model (1)
- mouse models (1)
- multifaceted approaches (1)
- multiple myeloma (1)
- mycobacterial infection (1)
- mycophenolic acid (1)
- myocyte (1)
- natamycin (1)
- natural killer cell (1)
- natural transformation (1)
- neglected groups (1)
- neoblast (1)
- neonatal morbidity (1)
- nitrite respiration (1)
- nitrites (1)
- non-aureus staphylococci (1)
- nonautonomous (1)
- nosocomial transmission (1)
- nuclear magnetic resonance (1)
- ocular infection (1)
- one-health approach (1)
- oral cefpodoxime (1)
- oral doxycycline (1)
- oral microbiome (1)
- organic farming (1)
- organoid (1)
- outpatient (1)
- oxidative stress (1)
- panton-valentine leukocidin (1)
- paradoxical effect (1)
- paradoxical growth (1)
- parasitic diseases (1)
- pathometabolism (1)
- pediatric (1)
- pediatrician (1)
- periprosthetic joint infection (1)
- phase variation (1)
- phylotypic (1)
- pig (1)
- pig farming methods (1)
- piperacillin (1)
- piperacillin/tazobactam (1)
- planarian (1)
- plexus epithelial-cells (1)
- pluripotency (1)
- polymorphonuclear neutrophils (1)
- population biology (1)
- population genetics (1)
- post-operative antibiotic treatment (1)
- primary care (1)
- primary cells (1)
- probe-based real-time PCR (1)
- protein kinases (1)
- proteins (1)
- proteomic analysis (1)
- public health (1)
- qPCR (1)
- quality of life (1)
- real-time PCR (1)
- recombinant proteins (1)
- regulator (1)
- regulatory T cells (1)
- relA (1)
- research infrastructure (1)
- resistance (1)
- retrotransposition (1)
- revision arthroplasty (1)
- schistoma mansoni (1)
- sensitivity (1)
- sensitivity and specificity (1)
- septic (1)
- sequence (1)
- sequence assembly tools (1)
- serogroup B (1)
- serogroup-Y (1)
- serology (1)
- seroprevalence (1)
- serum (1)
- single-molecule tracking (1)
- sirolimus (1)
- small RNA (1)
- small interfering RNAs (1)
- spa typing (1)
- sporidia (1)
- state-based model (1)
- stem cell transplantation (1)
- strain MC58 (1)
- strain specificity (1)
- stringent response (1)
- structural determination (1)
- super-resolution microscopy (1)
- surgical intra-abdominal infections (1)
- survey (1)
- systems biology (1)
- tapeworm (1)
- taxonomy (1)
- tazobactam (1)
- testing strategy (1)
- therapy (1)
- throat (1)
- tight junctions (1)
- topic ofloxacin (1)
- transcription factors (1)
- translational research (1)
- transplantation (1)
- transposable elements (1)
- ultrahigh-field MRI (1)
- under five children (1)
- upper extremity (1)
- utilization (1)
- vaccine development (1)
- vaccines (1)
- vesicles (1)
- viral load (1)
- virulence (1)
- virulenceregulatory evolution (1)
- vitrectomy (1)
- water microbiology (1)
- white blood cell count (1)
- whole blood ex vivo model (1)
- whole-blood infection assay (1)
- whole-blood model (1)
- zinc cluster transcription factor (1)
- γ-glutamyl cycle (1)
Institute
- Institut für Hygiene und Mikrobiologie (118) (remove)
Sonstige beteiligte Institutionen
- Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany (1)
- Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden (1)
- Department of Medicine A, University Hospital of Münster, Münster, Germany (1)
- Krankenhaushygiene und Antimicrobial Stewardship (1)
- Krankenhaushygiene und Antimicrobial Stewardship (Universitätsklinikum) (1)
- Research Center for Infectious Diseases (ZINF), University of Würzburg, Würzburg, Germany (1)
EU-Project number / Contract (GA) number
- 2016 FGR 0053 (1)
- 278864 (1)
- 847507 (1)
Disruption of the blood-brain barrier (BBB) is a hallmark event in the pathophysiology of bacterial meningitis. Several inflammatory mediators, such as tumor necrosis factor alpha (TNF-a), nitric oxide and matrix metalloproteinases (MMPs), contribute to this disruption. Here we show that infection of human brain microvascular endothelial cells (HBMEC) with Neisseria meningitidis induced an increase of permeability at prolonged time of infection. This was paralleled by an increase in MMP-8 activity in supernatants collected from infected cells. A detailed analysis revealed that MMP-8 was involved in the proteolytic cleavage of the tight junction protein occludin, resulting in its disappearance from the cell periphery and cleavage to a lower-sized 50-kDa protein in infected HBMEC. Abrogation of MMP-8 activity by specific inhibitors as well as transfection with MMP-8 siRNA abolished production of the cleavage fragment and occludin remained attached to the cell periphery. In addition, MMP-8 affected cell adherence to the underlying matrix. A similar temporal relationship was observed for MMP activity and cell detachment. Injury of the HBMEC monolayer suggested the requirement of direct cell contact because no detachment was observed when bacteria were placed above a transwell membrane or when bacterial supernatant was directly added to cells. Inhibition of MMP-8 partially prevented detachment of infected HBMEC and restored BBB permeability. Together, we established that MMP-8 activity plays a crucial role in disassembly of cell junction components and cell adhesion during meningococcal infection.
Introduction: Chronic nonbacterial osteomyelitis (CNO) is an inflammatory disorder of unknown etiology. In children and adolescents CNO predominantly affects the metaphyses of the long bones, but lesions can occur at any site of the skeleton. Prospectively followed cohorts using a standardized protocol in diagnosis and treatment have rarely been reported. Methods: Thirty-seven children diagnosed with CNO were treated with naproxen continuously for the first 6 months. If assessment at that time revealed progressive disease or no further improvement, sulfasalazine and short-term corticosteroids were added. The aims of our short-term follow-up study were to describe treatment response in detail and to identify potential risk factors for an unfavorable outcome. Results: Naproxen treatment was highly effective in general, inducing a symptom-free status in 43% of our patients after 6 months. However, four nonsteroidal anti-inflammatory drug (NSAID) partial-responders were additionally treated with sulfasalazine and short-term corticosteroids. The total number of clinical detectable lesions was significantly reduced. Mean disease activity estimated by the patient/physician and the physical aspect of health-related quality of life including functional ability (global assessment/childhood health assessment questionnaire and childhood health assessment questionnaire) and pain improved significantly. Forty-one percent of our patients showed radiological relapses, but 67% of them were clinically silent. Conclusions: Most children show a favorable clinical course in the first year of anti-inflammatory treatment with NSAIDs. Relapses and new radiological lesions can occur at any time and at any site in the skeleton but may not be clinically symptomatic. Whole-body magnetic resonance imaging proved to be very sensitive for initial and follow-up diagnostics.
Alveolar echinococcosis (AE) of human being caused by Echinococcus multilocularis is a rare but important zoonosis especially in tempered zones of middle Europe and Northern America with endemic character in many countries. Due to the long incubation period, various clinical manifestations, critical prognosis, and outcome AE presents a serious and severe disease. The primary focus of infection is usually the liver. Although secondary affection of visceral organs is possible extrahepatic AE is highly uncommon. Moreover, the involvement of bone and muscle presents with an even lower incidence. In the literature numerous cases on hepatic AE have been reported. However, extrahepatic AE involving bones and/or muscles was described very rarely. We report a case of an 80-year-old man with primary extrahepatic alveolar Echinococcosis of the lumbar spine and the psoas muscle. The etiology, diagnosis, differential diagnoses, treatment options and outcome of this rare disease are discussed in context with the current literature.
Visceral pentastomiasis caused by Armillifer armillatus larvae was diagnosed in 2 dogs in The Gambia. Parasites were subjected to PCR; phylogenetic analysis confirmed relatedness with branchiurans/crustaceans. Our investigation highlights transmission of infective A. armillatus ova to dogs and, by serologic evidence, also to 1 human, demonstrating a public health concern.
Background: Specific cell targeting is an important, yet unsolved problem in bacteria-based therapeutic applications, like tumor or gene therapy. Here, we describe the construction of a novel, internalin A and B (InlAB)-deficient Listeria monocytogenes strain (Lm-spa+), which expresses protein A of Staphylococcus aureus (SPA) and anchors SPA in the correct orientation on the bacterial cell surface. Results: This listerial strain efficiently binds antibodies allowing specific interaction of the bacterium with the target recognized by the antibody. Binding of Trastuzumab (Herceptin®) or Cetuximab (Erbitux®) to Lm-spa+, two clinically approved monoclonal antibodies directed against HER2/neu and EGFR/HER1, respectively, triggers InlABindependent internalization into non-phagocytic cancer cell lines overexpressing the respective receptors. Internalization, subsequent escape into the host cell cytosol and intracellular replication of these bacteria are as efficient as of the corresponding InlAB-positive, SPA-negative parental strain. This specific antibody/receptormediated internalization of Lm-spa+ is shown in the murine 4T1 tumor cell line, the isogenic 4T1-HER2 cell line as well as the human cancer cell lines SK-BR-3 and SK-OV-3. Importantly, this targeting approach is applicable in a xenograft mouse tumor model after crosslinking the antibody to SPA on the listerial cell surface. Conclusions: Binding of receptor-specific antibodies to SPA-expressing L. monocytogenes may represent a promising approach to target L. monocytogenes to host cells expressing specific receptors triggering internalization.
Background
Neisseria meningitidis is a naturally transformable, facultative pathogen colonizing the human nasopharynx. Here, we analyze on a genome-wide level the impact of recombination on gene-complement diversity and virulence evolution in N. meningitidis. We combined comparative genome hybridization using microarrays (mCGH) and multilocus sequence typing (MLST) of 29 meningococcal isolates with computational comparison of a subset of seven meningococcal genome sequences.
Principal Findings
We found that lateral gene transfer of minimal mobile elements as well as prophages are major forces shaping meningococcal population structure. Extensive gene content comparison revealed novel associations of virulence with genetic elements besides the recently discovered meningococcal disease associated (MDA) island. In particular, we identified an association of virulence with a recently described canonical genomic island termed IHT-E and a differential distribution of genes encoding RTX toxin- and two-partner secretion systems among hyperinvasive and non-hyperinvasive lineages. By computationally screening also the core genome for signs of recombination, we provided evidence that about 40% of the meningococcal core genes are affected by recombination primarily within metabolic genes as well as genes involved in DNA replication and repair. By comparison with the results of previous mCGH studies, our data indicated that genetic structuring as revealed by mCGH is stable over time and highly similar for isolates from different geographic origins.
Conclusions
Recombination comprising lateral transfer of entire genes as well as homologous intragenic recombination has a profound impact on meningococcal population structure and genome composition. Our data support the hypothesis that meningococcal virulence is polygenic in nature and that differences in metabolism might contribute to virulence.
The eradication of infectious agents is an attractive means of disease control that, to date, has been achieved for only one human pathogen, the smallpox virus. The introduction of vaccines against Neisseria meningitidis into immunisation schedules, and particularly the conjugate polysaccharide vaccines which can interrupt transmission, raises the question of whether disease caused by this obligate human bacterium can be controlled, eliminated, or even eradicated. The limited number of meningococcal serogroups, lack of an animal reservoir, and importance of meningococcal disease are considerations in favour of eradication; however, the commensal nature of most infections, the high diversity of meningococcal populations, and the lack of comprehensive vaccines are all factors that suggest that this is not feasible. Indeed, any such attempt might be harmful by perturbing the human microbiome and its interaction with the immune system. On balance, the control and possible elimination of disease caused by particular disease-associated meningococcal genotypes is a more achievable and worthwhile goal.
Background: Alveolar echinococcosis (AE) is caused by the metacestode stage of Echinococcus multilocularis. Differential diagnosis with cystic echinococcosis (CE) caused by E. granulosus and AE is challenging. We aimed at improving diagnosis of AE on paraffin sections of infected human tissue by immunohistochemical testing of a specific antibody.
Methodology/Principal Findings: We have analysed 96 paraffin archived specimens, including 6 cutting needle biopsies and 3 fine needle aspirates, from patients with suspected AE or CE with the monoclonal antibody (mAb) Em2G11 specific for the Em2 antigen of E. multilocularis metacestodes. In human tissue, staining with mAb Em2G11 is highly specific for E. multilocularis metacestodes while no staining is detected in CE lesions. In addition, the antibody detects small particles of E. multilocularis (spems) of less than 1 mm outside the main lesion in necrotic tissue, liver sinusoids and lymphatic tissue most probably caused by shedding of parasitic material. The conventional histological diagnosis based on haematoxylin and eosin and PAS stainings were in accordance with the immunohistological diagnosis using mAb Em2G11 in 90 of 96 samples. In 6 samples conventional subtype diagnosis of echinococcosis had to be adjusted when revised by immunohistology with mAb Em2G11.
Conclusions/Significance: Immunohistochemistry with the mAb Em2G11 is a new, highly specific and sensitive diagnostic tool for AE. The staining of small particles of E. multilocularis (spems) outside the main lesion including immunocompetent tissue, such as lymph nodes, suggests a systemic effect on the host.
Neisseria meningitidis employs polysaccharides and outer membrane proteins to cope with human serum complement attack. To screen for factors influencing serum resistance, an assay was developed based on a colorimetric serum bactericidal assay. The screening used a genetically modified sequence type (ST)-41/44 clonal complex (cc) strain lacking LPS sialylation, polysaccharide capsule, the factor H binding protein (fHbp) and MutS, a protein of the DNA repair mechanism. After killing of >99.9% of the bacterial cells by serum treatment, the colorimetric assay was used to screen 1000 colonies, of which 35 showed enhanced serum resistance. Three mutant classes were identified. In the first class of mutants, enhanced expression of Opc was identified. Opc expression was associated with vitronectin binding and reduced membrane attack complex deposition confirming recent observations. Lipopolysaccharide (LPS) immunotype switch from immunotype L3 to L8/L1 by lgtA and lgtC phase variation represented the second class. Isogenic mutant analysis demonstrated that in ST-41/44 cc strains the L8/L1 immunotype was more serum resistant than the L3 immunotype. Consecutive analysis revealed that the immunotypes L8 and L1 were frequently observed in ST-41/44 cc isolates from both carriage and disease. Immunotype switch to L8/L1 is therefore suggested to contribute to the adaptive capacity of this meningococcal lineage. The third mutant class displayed a pilE allelic exchange associated with enhanced autoaggregation. The mutation of the C terminal hypervariable region D of PilE included a residue previously associated with increased pilus bundle formation. We suggest that autoaggregation reduced the surface area accessible to serum complement and protected from killing. The study highlights the ability of meningococci to adapt to environmental stress by phase variation and intrachromosomal recombination affecting subcapsular antigens.